Conditions:   Skeletal Deformities;   Leg Length Discrepancy
Intervention:   Dietary Supplement: gastrolith calcium
Sponsor:   Hadassah Medical Organization
Not yet recruiting - verified February 2010

Condition:   Osteopetrosis
Interventions:   Drug: Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen);   Procedure: Stem Cell Transplantation;   Drug: Cyclosporin, Methotrexate (GVHD prophylaxis)
Sponsor:   Tehran University of Medical Sciences
Recruiting - verified March 2010

Condition:   Arthritis, Psoriatic
Interventions:   Biological: CZP 200mg Q2W;   Biological: CZP 400mg Q4W;   Other: Placebo
Sponsor:   UCB, Inc.
Recruiting - verified March 2010

Condition:   Spondolyarthropathies
Interventions:   Biological: Certolizumab pegol;   Biological: Certolizumab pegol;   Other: Placebo
Sponsor:   UCB, Inc.
Recruiting - verified March 2010

Condition:   Acromegaly
Interventions:   Drug: Octreotide acetate LAR;   Drug: Sandostatin LAR ® (octreotide acetate LAR) 30 MG
Sponsor:   L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
Not yet recruiting - verified March 2010

Condition:   Scoliosis
Interventions:   Device: Acoustic reflection method evaluation;   Radiation: EOS™;   Other: Non invasive respiratory muscle assessment
Sponsors:   Club d'Anesthésie-Réanimation Pédiatrique Armand Trousseau;   Ecole Nationale Supérieure des Arts et Metiers
Recruiting - verified December 2009

Conditions:   Bone Cancer;   Bone Metastases;   Pain
Intervention:   Device: ExAblate 2100
Sponsor:   InSightec
Not yet recruiting - verified March 2010

Conditions:   Sarcopenia;   Osteoporosis;   Aging
Interventions:   Drug: Acetaminophen;   Drug: Ibuprofen;   Behavioral: high intensity progressive resistance exercise training;   Drug: placebo
Sponsor:   University of Colorado, Denver
Active, not recruiting - verified March 2010

Conditions:   Rheumatoid Arthritis;   Arthritis, Psoriatic;   Ankylosing Spondylitis
Interventions:   Biological: golimumab;   Biological: anti-TNF biologics;   Biological: non-anti-TNF biologics;   Drug: systemic non-biological treatments;   Other: general population
Sponsor:   Centocor Ortho Biotech Services, L.L.C.
Not yet recruiting - verified March 2010

Condition:   Adult Growth Hormone Deficiency
Intervention:  
Sponsor:   Merck KGaA
Active, not recruiting - verified March 2010

Condition:   Lumbar Spinal Stenosis
Intervention:   Device: Minimally Invasive Lumbar Decompression (Mild®)
Sponsor:   Vertos Medical, Inc.
Not yet recruiting - verified March 2010

Condition:   Osteoporosis
Intervention:   Drug: FORTEO
Sponsor:   Eli Lilly and Company
Active, not recruiting - verified March 2010

Conditions:   Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis
Intervention:   Biological: HUMIRA (adalimumab)
Sponsors:   Abbott;   Veeda Clinical Research, Brussels
Recruiting - verified March 2010

Condition:   Ankylosing Spondylitis
Intervention:   Drug: adalimumab (Humira)
Sponsor:   Abbott
Recruiting - verified March 2010

Conditions:   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:  
Sponsors:   Abbott;   Group Data Management Biostatistics
Active, not recruiting - verified March 2010

Condition:   Gaucher Disease
Interventions:   Drug: Genz-112638;   Drug: Genz-112638
Sponsor:   Genzyme
Not yet recruiting - verified January 2010

Conditions:   Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis
Intervention:  
Sponsor:   Abbott
Recruiting - verified February 2010

Conditions:   Active Rheumatoid Arthritis;   Osteoporoses
Intervention:  
Sponsors:   Abbott;   Centre of Biostatistics and Analyses, Faculty of Medicine, Masaryk University Brno, Czech Republic
Recruiting - verified February 2010

Condition:   Esophageal Cancer
Intervention:  
Sponsors:   Merck;   World Health Information Science Consultants, LLC
Active, not recruiting - verified February 2010

Condition:   Ankylosing Spondylitis
Intervention:  
Sponsor:   Merck
Active, not recruiting - verified February 2010

Conditions:   Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis
Intervention:   Drug: adalimumab (Humira)
Sponsors:   Abbott;   Eisai Limited
Enrolling by invitation - verified March 2010

Condition:   Psoriatic Arthritis
Intervention:   Biological: adalimumab (Humira)
Sponsor:   Abbott
Not yet recruiting - verified February 2010

Condition:   Arthritis, Psoriatic
Interventions:   Drug: ustekinumab;   Drug: placebo;   Drug: placebo;   Drug: ustekinumab;   Drug: ustekinumab;   Drug: placebo;   Drug: ustekinumab;   Drug: ustekinumab
Sponsor:   Centocor, Inc.
Not yet recruiting - verified February 2010

Condition:   Lumbar Spinal Stenosis
Intervention:   Procedure: Minimally Invasive Lumbar Decompression
Sponsors:   The Center for Pain Relief, Inc.;   Vertos Medical
Recruiting - verified March 2010

Conditions:   Arthritis, Rheumatoid;   Spondylitis, Ankylosing
Intervention:   Drug: TNF blockers (infliximab, adalimumab, etanercept)
Sponsor:   University of Sao Paulo
Recruiting - verified January 2010

Condition:   Stem Cell Transplantation
Interventions:   Biological: Auto-hMSCs;   Biological: Allo-hMSCs
Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   University of Miami
Not yet recruiting - verified October 2009

Condition:   Primary Hyperparathyroidism
Intervention:   Procedure: Parathyroid surgery
Sponsor:   Region Skane
Not yet recruiting - verified March 2010

Conditions:   Chronic Lymphocytic Leukemia (CLL);   Diffuse Large B-Cell Lymphoma (DLBCL);   Non-Hodgkin's Lymphoma (NHL);   Follicular Lymphoma (FL);   Mantle Cell Lymphoma (MCL)
Intervention:   Drug: CAT-8015
Sponsor:   National Cancer Institute (NCI)
Recruiting - verified January 2010

Conditions:   Hairy Cell Leukemia (HCL);   Chronic Lymphocytic Leukemia (CLL);   Non-Hodgkins Lymphoma (NHL);   Cutaneous T Cell Lymphoma (CTCL);   Adult T Cell Lymphoma (ATL)
Intervention:  
Sponsor:   National Cancer Institute (NCI)
Recruiting - verified January 2010

Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: autologous bone marrow-derived stem cells
Sponsor:   TCA Cellular Therapy
Recruiting - verified March 2010

Condition:   Prostate Cancer
Interventions:   Drug: Testosterone;   Drug: Etoposide
Sponsor:   Sidney Kimmel Comprehensive Cancer Center
Recruiting - verified March 2010

Condition:   Heart Failure
Intervention:   Other: Surgery
Sponsor:   University Medical Centre Groningen
Not yet recruiting - verified March 2010

Condition:   Prostatic Neoplasms
Intervention:   Drug: Ascorbic Acid (Vitamin C)
Sponsors:   Copenhagen University Hospital at Herlev;   Rigshospitalet, Denmark;   University of Copenhagen
Not yet recruiting - verified March 2010

Conditions:   Leukemia;   Mucositis;   Oral Complications
Interventions:   Biological: epratuzumab;   Biological: palifermin;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: fludarabine phosphate;   Drug: imatinib mesylate;   Drug: melphalan;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: nelarabine;   Drug: pegaspargase;   Drug: vincristine sulfate;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: assessment of therapy complications;   Radiation: total-body irradiation
Sponsor:   University College London Hospitals
Recruiting - verified March 2010

Condition:   Hypercholesterolemia
Intervention:   Drug: Simvastatin
Sponsor:   Hadassah Medical Organization
Not yet recruiting - verified March 2010

Condition:   Chronic Periodontitis
Intervention:   Biological: cell sheet pellets and cell sheet fragment
Sponsor:   Fourth Military Medical University
Active, not recruiting - verified October 2009

Condition:   Leukemia, Lymphocytic, Acute
Interventions:   Procedure: bone marrow aspiration;   Procedure: peripheral blood sampling
Sponsor:   Stanford University
Completed - verified February 2010

Condition:   Hyperprolactinemia
Intervention:   Drug: Aripiprazole
Sponsors:   University of Oxford;   National Institute for Health Research, United Kingdom
Not yet recruiting - verified March 2010

Conditions:   Humeral Fractures;   Pathological Fractures
Intervention:   Device: Quantum
Sponsor:   N.M.B. Medical Applications Ltd
Not yet recruiting - verified February 2010

Condition:   Non-Alcoholic Fatty Liver Disease
Interventions:   Drug: Galvus (vitagliptin);   Drug: Galvus + vitamin D
Sponsor:   Ziv Hospital
Not yet recruiting - verified March 2010

Condition:   Myelodysplastic Syndrome
Intervention:   Drug: Erlotinib
Sponsors:   Groupe Francophone des Myelodysplasies;   Roche Pharma AG
Active, not recruiting - verified March 2010

Conditions:   Infection;   Osteoarthritis of the Knee
Interventions:   Device: Simplex™ P with Tobramycin;   Device: Simplex™ P
Sponsor:   University of Western Ontario, Canada
Not yet recruiting - verified March 2010

Condition:   Multiple Myeloma
Interventions:   Drug: zoledronic acid;   Other: No treatment control
Sponsors:   PETHEMA Foundation;   Dynamic Solutions S.L. (Contract Research Organization);   Novartis Farmacéutica S.A
Not yet recruiting - verified March 2010

Conditions:   Parathyroid Adenoma;   Thyroid Adenoma
Intervention:  
Sponsor:   Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified March 2010

Conditions:   Accelerated Phase Chronic Myelogenous Leukemia;   Adult Acute Lymphoblastic Leukemia in Remission;   Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With T(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With T(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With T(8;21)(q22;q22);   Atypical Chronic Myeloid Leukemia;   Blastic Phase Chronic Myelogenous Leukemia;   Chronic Phase Chronic Myelogenous Leukemia;   De Novo Myelodysplastic Syndromes;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Myelodysplastic/Myeloproliferative Disease, Unclassifiable;   Nodal Marginal Zone B-cell Lymphoma;   Noncontiguous Stage II Adult Burkitt Lymphoma;   Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma;   Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma;   Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma;   Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma;   Noncontiguous Stage II Adult Lymphoblastic Lymphoma;   Noncontiguous Stage II Grade 1 Follicular Lymphoma;   Noncontiguous Stage II Grade 2 Follicular Lymphoma;   Noncontiguous Stage II Grade 3 Follicular Lymphoma;   Noncontiguous Stage II Mantle Cell Lymphoma;   Noncontiguous Stage II Marginal Zone Lymphoma;   Noncontiguous Stage II Small Lymphocytic Lymphoma;   Previously Treated Myelodysplastic Syndromes;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Small Lymphocytic Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Hairy Cell Leukemia;   Refractory Multiple Myeloma;   Relapsing Chronic Myelogenous Leukemia;   Secondary Acute Myeloid Leukemia;   Secondary Myelodysplastic Syndromes;   Splenic Marginal Zone Lymphoma;   Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Adult Burkitt Lymphoma;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage III Adult Diffuse Mixed Cell Lymphoma;   Stage III Adult Diffuse Small Cleaved Cell Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage III Adult Immunoblastic Large Cell Lymphoma;   Stage III Adult Lymphoblastic Lymphoma;   Stage III Chronic Lymphocytic Leukemia;   Stage III Grade 1 Follicular Lymphoma;   Stage III Grade 2 Follicular Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage III Mantle Cell Lymphoma;   Stage III Marginal Zone Lymphoma;   Stage III Multiple Myeloma;   Stage III Small Lymphocytic Lymphoma;   Stage IV Adult Burkitt Lymphoma;   Stage IV Adult Diffuse Large Cell Lymphoma;   Stage IV Adult Diffuse Mixed Cell Lymphoma;   Stage IV Adult Diffuse Small Cleaved Cell Lymphoma;   Stage IV Adult Hodgkin Lymphoma;   Stage IV Adult Immunoblastic Large Cell Lymphoma;   Stage IV Adult Lymphoblastic Lymphoma;   Stage IV Chronic Lymphocytic Leukemia;   Stage IV Grade 1 Follicular Lymphoma;   Stage IV Grade 2 Follicular Lymphoma;   Stage IV Grade 3 Follicular Lymphoma;   Stage IV Mantle Cell Lymphoma;   Stage IV Marginal Zone Lymphoma;   Stage IV Small Lymphocytic Lymphoma
Interventions:   Drug: plerixafor;   Biological: filgrastim;   Procedure: peripheral blood stem cell transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation
Sponsor:   Fred Hutchinson Cancer Research Center
Not yet recruiting - verified February 2010

Conditions:   Breast Cancer;   Bone Metastases
Intervention:   Drug: Radium-223 chloride (Alpharadin)
Sponsor:   Algeta ASA
Recruiting - verified March 2010

Conditions:   Monoclonal Gammopathy of Undetermined Significance;   Smoldering Myeloma
Intervention:   Genetic: Genetic study of DNA copies
Sponsors:   Rennes University Hospital;   Intergroupe Francophone du Myelome
Recruiting - verified March 2010

Conditions:   Leukemia, Myelogenous, Acute;   Myelodysplastic Syndromes
Intervention:   Drug: Oxi4503
Sponsor:   University of Florida
Not yet recruiting - verified March 2010

Condition:   Bone-Metastatic, Castration-Resistant Prostate Cancer
Intervention:   Drug: KX2-391
Sponsor:   Kinex Pharmaceuticals, LLC
Recruiting - verified March 2010

Condition:   Myelodysplastic Syndromes
Intervention:   Drug: Lenalidomide
Sponsors:   Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH;   ClinAssess - Gesellschaft für klinische Forschung mbH
Recruiting - verified March 2010

Conditions:   Bone Marrow;   Bone Marrow Stromal Cells;   Mesenchymal Stem Cells;   Blood Donors
Intervention:  
Sponsor:   National Institutes of Health Clinical Center (CC)
Recruiting - verified January 2010

Condition:   Fanconi Anemia
Interventions:   Drug: Chemotherapy Preparative Regimen;   Biological: Miltenyi CliniMACS
Sponsor:   Children's Hospital Medical Center, Cincinnati
Recruiting - verified March 2010

Condition:   Lupus Nephritis
Interventions:   Drug: laquinimod 0.5mg + standard of care;   Drug: laquinimod 1mg + standard of care;   Other: placebo + standard of care
Sponsor:   Teva Pharmaceutical Industries
Not yet recruiting - verified March 2010

Conditions:   Busulfan Pharmacokinetic Analysis;   GST Genetic Polymorphism
Intervention:   Drug: Hematological Stem Cell Transplantation
Sponsors:   Rambam Health Care Campus;   Israel Cancer Association
Recruiting - verified May 2009

Condition:   Acute Gout
Interventions:   Drug: ACZ885;   Drug: Triamcinolone acetonide
Sponsor:   Novartis Pharmaceuticals
Recruiting - verified March 2010

Conditions:   Cancer Survivor;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Neuroblastoma;   Testicular Germ Cell Tumor
Interventions:   Genetic: DNA analysis;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: laboratory biomarker analysis
Sponsors:   Vanderbilt-Ingram Cancer Center;   National Cancer Institute (NCI)
Recruiting - verified February 2010

Conditions:   Growth Disorders;   Intrauterine Growth Retardation
Interventions:   Drug: Genotonorm;   Drug: Genotonorm;   Drug: Genotonorm
Sponsor:   Pfizer
Completed - verified February 2010

Condition:   Displaced Midshaft Fracture of the Collar Bone
Interventions:   Procedure: Operation using a precontoured titanium plate and screws;   Procedure: Displaced midshaft fracture of the collar bone treated with an arm sling
Sponsors:   Northern Orthopaedic Division, Denmark;   Viborg Hospital;   Vejle Hospital;   Randers Region Hospital;   Swemac Orthopaedics ApS
Not yet recruiting - verified February 2010

Conditions:   Renal Insufficiency;   Secondary Hyperparathyroidism
Intervention:   Drug: Zemplar (paricalcitol)
Sponsor:   Abbott
Recruiting - verified March 2010

Condition:   Fracture Healing
Interventions:   Drug: AMG 785 140 mg;   Drug: AMG785 70mg;   Drug: AMG 785 210mg;   Drug: Placebo
Sponsor:   Amgen
Not yet recruiting - verified March 2010

Condition:   Uterine Cervical Neoplasms
Intervention:   Drug: [F18]Fluorothymidine
Sponsors:   University of Iowa;   Holden Comprehensive Cancer Center
Recruiting - verified February 2010

Condition:   PROSTATE CANCER.
Interventions:   Drug: Docetaxel and Prednisone;   Drug: Docetaxel and Prednisone;   Drug: Radiation Therapy
Sponsors:   Northwestern University;   Genzyme
Not yet recruiting - verified March 2010

Conditions:   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With T(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With T(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With T(8;21)(q22;q22);   Childhood Myelodysplastic Syndromes;   Chronic Myelomonocytic Leukemia;   Previously Treated Myelodysplastic Syndromes;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Secondary Myelodysplastic Syndromes
Interventions:   Drug: azacitidine;   Drug: gemtuzumab ozogamicin
Sponsor:   Fred Hutchinson Cancer Research Center
Not yet recruiting - verified March 2010

Conditions:   Atopic Dermatitis;   Psoriasis
Interventions:   Drug: Vitamin D3;   Drug: Placebo
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Food and Drug Administration (FDA);   University of California, San Diego
Completed - verified February 2010

Conditions:   Chronic Myeloid Leukemia;   Acute Lymphoblastic Leukemia
Intervention:   Drug: Nilotinib
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting - verified February 2010

Conditions:   Respiratory Tract Infections;   Influenza
Interventions:   Dietary Supplement: Cholecalciferol (Vitamin D/Vigantol oil);   Dietary Supplement: Miglyol oil
Sponsors:   Barts & The London NHS Trust;   National Health Service, United Kingdom
Not yet recruiting - verified February 2010

Conditions:   Hyperphosphatemia;   End-Stage Renal Disease
Intervention:   Drug: ferric citrate
Sponsor:   Keryx Biopharmaceuticals
Not yet recruiting - verified February 2010

Condition:   Prostatic Neoplasm
Intervention:   Drug: leuprolide (Lucrin/Lucrin-Tri-depot)
Sponsor:   Abbott
Active, not recruiting - verified March 2010

Conditions:   Rotator Cuff Tear;   Proximal Humerus Fractures;   Malunions;   Chronic Proximal Humerus Dislocations
Intervention:  
Sponsor:   Loma Linda University
Not yet recruiting - verified March 2010

Conditions:   Hip Fracture;   Surgical Intervention
Intervention:   Drug: Iron sucrose
Sponsor:   Hospital Clinic of Barcelona
Not yet recruiting - verified January 2010

Condition:   Healthy Volunteers
Interventions:   Dietary Supplement: Single High Dose Cholecalciferol;   Dietary Supplement: Daily Dose Cholecalciferol
Sponsor:   Mayo Clinic
Recruiting - verified March 2010

Condition:   Breast Cancer
Intervention:   Drug: letrozole
Sponsors:   University of Arizona;   National Cancer Institute (NCI)
Not yet recruiting - verified February 2010

Condition:   Atherosclerosis
Intervention:  
Sponsor:   Assaf-Harofeh Medical Center
Active, not recruiting - verified February 2010

Condition:   Hepatitis B Virus
Interventions:   Drug: Peginterferon + Vitamin D;   Drug: Peginterferon;   Drug: Sebivo
Sponsor:   Ziv Hospital
Not yet recruiting - verified March 2010

Conditions:   Breast Cancer;   CYP2D6 Polymorphism
Intervention:   Drug: Tamoxifen
Sponsor:   Sydney West Area Health Service
Not yet recruiting - verified February 2010

Condition:   Chronic Myeloid Leukemia
Intervention:   Other: Discontinuation of therapy
Sponsor:   University of Michigan Cancer Center
Recruiting - verified February 2010

Conditions:   Fracture;   Infection, Human Immunodeficiency Virus
Interventions:   Other: No Antiretroviral (ARV) Drug Exposure;   Drug: Any Antiretroviral (ARV) Drug Exposure
Sponsor:   GlaxoSmithKline
Active, not recruiting - verified March 2010

Condition:   Familial Hypercholesterolaemia
Interventions:   Drug: rosuvastatin calcium;   Drug: rosuvastatin calcium;   Drug: rosuvastatin calcium
Sponsor:   AstraZeneca
Recruiting - verified March 2010

Condition:   Breast Cancer
Intervention:   Drug: Letrozole
Sponsor:   Korean Breast Cancer Study Group
Enrolling by invitation - verified February 2010

Condition:   Colorectal Cancer
Intervention:   Dietary Supplement: vitamin D repletion with Cholecalciferol (vitamin D3 50,000 International Units)
Sponsor:   Memorial Sloan-Kettering Cancer Center
Recruiting - verified February 2010

Conditions:   Insulin Resistance;   Glucose Intolerance
Interventions:   Drug: Colecalciferol (Vitamin D3) 300.000 UI;   Drug: Placebo
Sponsor:   Hospital de Clinicas de Porto Alegre
Enrolling by invitation - verified February 2010

Condition:   Chronic Migraine
Interventions:   Drug: Botox;   Drug: Placebo
Sponsors:   Cady, Roger, M.D.;   Allergan
Not yet recruiting - verified February 2010

Conditions:   Fracture;   Ultrasonography
Intervention:  
Sponsor:   University of Aarhus
Recruiting - verified February 2010

Conditions:   Apoplexy;   Femoral Neck Fracture;   Myocardial Infarction;   Subarachnoid Hemorrhage;   Polytrauma
Intervention:  
Sponsors:   Ruhr University of Bochum;   Workers' Samaritan Federation Germany
Completed - verified February 2010

Conditions:   Acute Lymphocytic Leukemia;   Acute Myeloid Leukemia;   Myelodysplastic Syndrome;   Chronic Myelogenous Leukemia
Interventions:   Drug: bortezomib;   Drug: belinostat;   Other: laboratory biomarker analysis;   Genetic: western blotting;   Other: pharmacological study;   Other: flow cytometry
Sponsors:   Virginia Commonwealth University;   National Cancer Institute (NCI)
Not yet recruiting - verified February 2010